Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Challenges and controversies in resectable non-small cell lung cancer: a clinician’s perspective
Ilias Houda, Chris Dickhoff, Carin A. Uyl‐de Groot, et al.
The Lancet Regional Health - Europe (2024) Vol. 38, pp. 100841-100841
Open Access | Times Cited: 20

Showing 20 citing articles:

Nose-on-Chip Nanobiosensors for Early Detection of Lung Cancer Breath Biomarkers
Vishal Chaudhary, Bakr Ahmed Taha, Lucky Lucky, et al.
ACS Sensors (2024) Vol. 9, Iss. 9, pp. 4469-4494
Open Access | Times Cited: 27
Future perspective for the application of predictive biomarker testing in advanced stage non-small cell lung cancer
Vincent D. de Jager, Wim Timens, Arnaud Bayle, et al.
The Lancet Regional Health - Europe (2024) Vol. 38, pp. 100839-100839
Open Access | Times Cited: 26
Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countries
Vincent D. de Jager, Wim Timens, Arnaud Bayle, et al.
The Lancet Regional Health - Europe (2024) Vol. 38, pp. 100838-100838
Open Access | Times Cited: 24
New systemic treatment paradigms in resectable non-small cell lung cancer and variations in patient access across Europe
Ilias Houda, Chris Dickhoff, Carin A. Uyl‐de Groot, et al.
The Lancet Regional Health - Europe (2024) Vol. 38, pp. 100840-100840
Open Access | Times Cited: 15
Advances in Non-Small Cell Lung Cancer: Current Insights and Future Directions
Pankaj Garg, Sulabh Singhal, Prakash Kulkarni, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 14, pp. 4189-4189
Open Access | Times Cited: 10
A Novel Deep Learning Approach for Accurate Cancer Type and Subtype Identification
Jabed Omar Bappi, Mohammad Abu Tareq Rony, Mohammad Shariful Islam, et al.
IEEE Access (2024) Vol. 12, pp. 94116-94134
Open Access | Times Cited: 4
Neoadjuvant immunotherapy strategies for resectable non-small cell lung cancer (NSCLC): Current evidence among special populations and future perspectives
Claudia Parisi, Pamela Abdayem, Marco Tagliamento, et al.
Cancer Treatment Reviews (2024) Vol. 131, pp. 102845-102845
Closed Access | Times Cited: 4
Chromosomal passenger complex-cyclin/CDK axis correlated with poor lung cancer prognosis
Prerna Vats, Sakshi Nirmal, Ashok Kumar, et al.
Journal of Biomedical Research (2025) Vol. 39, pp. 1-1
Open Access
Real-World Treatment Patterns and Outcomes Among Patients with Early Non-Small Cell Lung Cancer
Jennifer D. Deem, Zsolt Hepp, Joshua J. Carlson
Current Oncology (2025) Vol. 32, Iss. 4, pp. 239-239
Open Access
Disparity of the Treatment of Unresectable Non-small Cell Lung Cancer Regarding Chemotherapy: A Systematic Review and Meta-Analysis
Ryuichi Ohta, Chiaki Sano
Cureus (2024)
Open Access | Times Cited: 2
A regret theory-based even swaps method with complex linguistic information and its application in early-stage lung cancer treatment selection
Huchang Liao, Yangchao Xu, Ran Fang
Information Sciences (2024) Vol. 681, pp. 121194-121194
Closed Access | Times Cited: 1
Medical costs of lung cancer by stage, histology and first-line treatment modality in the Netherlands (2012–2021)
Koen de Nijs, Harry J. de Koning, Carlijn van der Aalst, et al.
European Journal of Cancer (2024) Vol. 208, pp. 114231-114231
Open Access | Times Cited: 1
The Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group: outstanding contribution and entering a new phase
Kazuo Nakagawa, Masaya Yotsukura, Takahiro Mimae, et al.
Japanese Journal of Clinical Oncology (2024) Vol. 54, Iss. 12, pp. 1237-1243
Closed Access | Times Cited: 1
Solving access to lung cancer care across Europe
Eric D. Brooks, Alexandra N. De Leo
The Lancet Regional Health - Europe (2024) Vol. 38, pp. 100873-100873
Open Access
Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish lung cancer group GECP. Controversies and discussion
Arturo Navarro Martín, Núria Rodríguez, José Luis López Guerra, et al.
Clinical & Translational Oncology (2024)
Closed Access
Association Between PD-L1 Score and the Outcomes of Consolidation Durvalumab in a Large Nationwide Series of Patients With Stage III NSCLC Treated With Chemoradiotherapy
Ronald Damhuis, Idris Bahce, Suresh Senan
Clinical Lung Cancer (2024) Vol. 25, Iss. 8, pp. 683-689
Closed Access
Real-World Analysis of Survival and Treatment Efficacy in Stage IIIA-N2 Non-Small Cell Lung Cancer
Eleni Josephides, Roberta Dunn, Annie-Rose Henry, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 3058-3058
Open Access
Cost-effectiveness analysis of a lung cancer screening program in the netherlands: a simulation based on NELSON and NLST study outcomes
Hilde ten Berge, B.A. Willems, Xuanqi Pan, et al.
Journal of Medical Economics (2024), pp. 1-47
Open Access
Biosynthesis of pH-Responsive Mesoporous Silica Nanoparticles from Cucumber Peels for Targeting 3D Lung Tumor Spheroids
Tamanna Bhuyan, Konika Choudhury, P. K. Das, et al.
ACS Applied Bio Materials (2024) Vol. 7, Iss. 11, pp. 7494-7508
Closed Access
Predictive and prognostic factors in patients with Anaplastic Lymphoma Kinase: rearranged early-stage lung adenocarcinoma
Filippo Tommaso Gallina, Fabiana Letizia Cecere, Riccardo Tajè, et al.
European Journal of Cardio-Thoracic Surgery (2024) Vol. 66, Iss. 5
Closed Access
Page 1

Scroll to top